Login / Signup

Oral Bioavailability of Omega-3 Fatty Acids and Carotenoids from the Microalgae Phaeodactylum tricornutum in Healthy Young Adults.

Lena StiefvatterKatja LehnertKonstantin FrickAlexander Montoya-ArroyoTheresia JumbeWalter VetterUlrike Schmid-StaigerStephan C Bischoff
Published in: Marine drugs (2021)
The microalgae Phaeodactylum tricornutum (PT) contains valuable nutrients such as proteins, polyunsaturated omega-3 fatty acids ( n -3 PUFA), particularly eicosapentaenoic acid (EPA) and some docosahexaenoic acid (DHA), carotenoids such as fucoxanthin (FX), and beta-glucans, which may confer health benefits. In a randomized intervention trial involving 22 healthy individuals, we administered for two weeks in a crossover manner the whole biomass of PT (5.3 g/day), or fish oil (FO) containing equal amounts of EPA and DHA (together 300 mg/day). In an additional experiment, sea fish at 185 g/week resulting in a similar EPA and DHA intake was administered in nine individuals. We determined the bioavailability of fatty acids and carotenoids and assessed safety parameters. The intake of PT resulted in a similar increase in the n -3 PUFA and EPA content and a decrease in the PUFA n -6: n -3 ratio in plasma. PT intake caused an uptake of FX that is metabolized to fucoxanthinol (FXOH) and amarouciaxanthin A (AxA). No relevant adverse effects occurred following PT consumption. The study shows that PT is a safe and effective source of EPA and FX-and likely other nutrients-and therefore should be considered as a future sustainable food item.
Keyphrases
  • fatty acid
  • young adults
  • randomized controlled trial
  • healthcare
  • weight gain
  • clinical trial
  • public health
  • heavy metals
  • mental health
  • study protocol
  • anaerobic digestion
  • body mass index
  • human health
  • phase ii